SSSanjay Srivatsa

Sanjay Srivatsa

*This is an algorithmically generated author record based on publicly available information.

Sanjay Srivatsa has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Role of Statins in the Primary Prevention of Atherosclerotic Cardiovascular Disease and Mortality in the Population with Mean Cholesterol in the Near-Optimal to Borderline High Range: A Systematic Review and Meta-Analysis

    by Bishnu Mohan Singh, Hari Krishna Lamichhane, Sanjay S. Srivatsa, Prabhat Adhikari, Bikash Jang Kshetri, Sijan Khatiwada, Dhan B. Shrestha

    Objective: The objective of this meta-analysis was to analyze the benefits and harms of treating the population with statins in those having mean low-density lipoprotein cholesterol (LDL-C) in the near-optimal (100 to 129 mg/dl) to borderline high (130 to 159 mg/dl) range and free of cardiovascular disease (CVD). Methods: We searched PubMed, PubMed Central, Cochrane Library, and Google Scholar databases for randomized controlled trials (RCTs) published between 1994 and July 2020. We included RCTs with greater than 90% of participants free of CVD. Two reviewers independently screened the articles using the Covidence software, assessed the methodological quality using the risk of bias 2 tool, and analyzed the data using the RevMan 5.4 software. Results: Eleven trials were included. Statin therapy was associated with a decreased risk of myocardial infarction (RR=0.56, 95% CI: 0.47 to 0.67), major cerebrovascular events (RR=0.78, 95% CI: 0.63 to 0.96), major coronary events (RR=0.67, 95% CI: 0.57 to 0.80), composite cardiovascular outcome (RR=0.71, 95% CI: 0.62 to 0.82), revascularizations (RR=0.65, 95% CI: 0.57 to 0.74), angina (RR=0.76, 95% CI: 0.63 to 0.92) and hospitalization for cardiovascular causes (RR=0.74, 95% CI: 0.64 to 0.86). There was no benefit associated with statin therapy for cardiovascular mortality and coronary heart disease mortality. All-cause mortality benefit with statin therapy was seen in the population with diabetes and increased risk of CVD. Statin therapy was associated with no significant increased risk of myalgia, creatine kinase elevation, rhabdomyolysis, myopathy, incidence of any cancer, incidence of diabetes, withdrawal of the drug due to adverse events, serious adverse events, fatal cancer, and liver enzyme abnormalities. Conclusion: Statin therapy was associated with a reduced risk of cardiovascular disease and procedures without increased risk of harm in populations with mean LDL-C near-optimal to the borderline high range without prior atherosclerotic cardiovascular disease.


  • Open Access

    A Dynamic Systems Approach for Detecting and Localizing of Infarct-Related Artery in Acute Myocardial Infarction Using Compressed Paper-Based Electrocardiogram (ECG)

    by Trung Q. Le, Vibhuthi Chandra, Kahkashan Afrin, Sanjay Srivatsa, Satish Bukkapatnam

    Timely evaluation and reperfusion have improved the myocardial salvage and the subsequent recovery rate of the patients hospitalized with acute myocardial infarction (MI). Long waiting time and time-consuming procedures of in-hospital diagnostic testing severely affect the timeliness. We present a Poincare pattern ensemble-based method with the consideration of multi-correlated non-stationary stochastic system dynamics to localize the infarct-related artery (IRA) in acute MI by fully harnessing information from paper-based Electrocardiogram (ECG). The vectorcardiogram (VCG) diagnostic features extracted from only 2.5-s long paper ECG recordings were used to hierarchically localize the IRA—not mere localization of the infarcted cardiac tissues—in acute MI. Paper ECG records and angiograms of 106 acute MI patients collected at the Heart Artery and Vein Center at Fresno California and the 12-lead ECG signals from the Physionet PTB online database were employed to validate the proposed approach. We reported the overall accuracies of 97.41% for healthy control (HC) vs. MI, 89.41 ± 9.89 for left and right culprit arteries vs. others, 88.2 ± 11.6 for left main arteries vs. right-coronary-ascending (RCA) and 93.67 ± 4.89 for left-anterior-descending (LAD) vs. left-circumflex (LCX). The IRA localization from paper ECG can be used to timely triage the patients with acute coronary syndromes to the percutaneous coronary intervention facilities.


  • Open Access

    Prognostic value of frontal QRS-T angle in predicting survival after primary percutaneous coronary revascularization/coronary artery bypass grafting for ST-elevation myocardial infarction

    by Abhishek C. Sawant, Aishwarya Bhardwaj, Shantanu Srivatsa, Srilekha Sridhara, Meghana Prakash Hiriyur Prakash, Nidhi Kanwar, Janelle Rodriguez, Gary Tse, Tong Liu, Arnav Kumar, et al.


  • Open Access

    Simultaneous 12-Lead Electrocardiogram Synthesis using a Single-Lead ECG Signal: Application to Handheld ECG Devices

    by Kahkashan Afrin, Parikshit Verma, Sanjay S. Srivatsa, Satish T. S. Bukkapatnam

    Recent introduction of wearable single-lead ECG devices of diverse configurations has caught the intrigue of the medical community. While these devices provide a highly affordable support tool for the caregivers for continuous monitoring and to detect acute conditions, such as arrhythmia, their utility for cardiac diagnostics remains limited. This is because clinical diagnosis of many cardiac pathologies is rooted in gleaning patterns from synchronous 12-lead ECG. If synchronous 12-lead signals of clinical quality can be synthesized from these single-lead devices, it can transform cardiac care by substantially reducing the costs and enhancing access to cardiac diagnostics. However, prior attempts to synthesize synchronous 12-lead ECG have not been successful. Vectorcardiography (VCG) analysis suggests that cardiac axis synthesized from earlier attempts deviates significantly from that estimated from 12-lead and/or Frank lead measurements. This work is perhaps the first successful attempt to synthesize clinically equivalent synchronous 12-lead ECG from single-lead ECG. Our method employs a random forest machine learning model that uses a subject's historical 12-lead recordings to estimate the morphology including the actual timing of various ECG events (relative to the measured single-lead ECG) for all 11 missing leads of the subject. Our method was validated on two benchmark datasets as well as paper ECG and AliveCor-Kardia data obtained from the Heart, Artery, and Vein Center of Fresno, California. Results suggest that this approach can synthesize synchronous ECG with accuracies (R2) exceeding 90%. Accurate synthesis of 12-lead ECG from a single-lead device can ultimately enable its wider application and improved point-of-care (POC) diagnostics.


  • Open Access

    Balanced Random Survival Forests for Extremely Unbalanced, Right Censored Data

    by Kahkashan Afrin, Gurudev Illangovan, Sanjay S. Srivatsa, Satish T. S. Bukkapatnam

    Accuracies of survival models for life expectancy prediction as well as critical-care applications are significantly compromised due to the sparsity of samples and extreme imbalance between the survival (usually, the majority) and mortality class sizes. While a recent random survival forest (RSF) model overcomes the limitations of the proportional hazard assumption, an imbalance in the data results in an underestimation (overestimation) of the hazard of the mortality (survival) classes. A balanced random survival forests (BRSF) model, based on training the RSF model with data generated from a synthetic minority sampling scheme is presented to address this gap. Theoretical results on the effect of balancing on prediction accuracies in BRSF are reported. Benchmarking studies were conducted using five datasets with different levels of class imbalance from public repositories and an imbalanced dataset of 267 acute cardiac patients, collected at the Heart, Artery, and Vein Center of Fresno, CA. Investigations suggest that BRSF provides an improved discriminatory strength between the survival and the mortality classes. It outperformed both optimized Cox (without and with balancing) and RSF with an average reduction of 55\% in the prediction error over the next best alternative.

    • 1 February 2015
      • Vol. 27  (2) , 121-7

    Mynx vascular closure device achieves reliable closure and hemostasis of percutaneous transfemoral venous access in a porcine vascular model.

    by S Sanjay Srivatsa, Arjun Srivatsa, Taylor A Spangler

    Vascular closure device (VCD)-based venous closure has been anecdotally reported, but systematic evaluation of the reparative response of the vessel wall to venous closure is lacking. The need to control groin complications, and minimize risks associated with postponed sheath removal under conditions of persistent anticoagulation, has generated interest in the role of VCDs for venous access closure. We sought to characterize the vessel wall response to venous closure, both acutely and in delayed fashion at 30 days using angiography, ultrasound, and histology. Ten venous 7 Fr sheaths were deployed in the femoral veins of swine. Bilateral venous access sites were subsequently closed utilizing manual compression (MC; control arm: n = 4) or a closure device utilizing an extravascular polyethylene glycol sealant (MynxGrip treatment arm: n = 6). Acute (post closure), 3-day, and 30-day vascular ultrasound, as well as venography (internal jugular approach) were used to assess outcomes. Gross pathology and histology were obtained at the 30-day endpoint for all femoral venous closure sites. Hemostasis was successfully achieved in all cases without access-site complications. Venography and ultrasound confirmed normal ilio-femoral anatomy and flow at all study time points. Gross pathology and histopathology revealed no evidence of deep vein thrombosis, and no abnormalities were seen in the vena cava, heart, or lungs. Histology at 30 days showed complete healing of the vein wall access site, with a small focus of chronic inflammation and fibrosis in the perivascular adventitial tissue of the access tract. There was no microscopic evidence of the sealant. The tissue tract showed mild discrete inflammation (foamy macrophages, lymphocytes, plasma cells) with microgranulomas centered on residual red cells in both treatment and control groups. This study characterizes the angiographic, ultrasound, and histopathology outcomes of femoral vein closure, and provides insight into the healing mechanisms following venotomy. The bio-resorptive role of MynxGrip extravascular sealant in achieving effective venous closure and preserved long-term vessel patency without venous thromboembolism is demonstrated.